c-erbB-2 in breast cancer: Development of a clinically useful marker
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference107 articles.
1. A tumor marker utility grading system (TMUGS): A framework to evaluate clinical utility of tumor markers;Hayes;J Natl Cancer Inst,1996
2. Assessing the clinical impact of prognostic factors: When is “statistically significant” clinically useful?;Hayes;Breast Cancer Res Treat,1998
3. Do we need prognostic factors in nodal-negative breast cancer? Arbiter;Hayes;Eur J Cancer,2000
4. Treatment of metastatic disease;Ellis,2000
5. Tamoxifen for early breast cancer: An overview of the randomized trials;Early Breast Cancer Trialist's Collaborative Group;Lancet,1998
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chaperone-assisted E3 ligase CHIP: A double agent in cancer;Genes & Diseases;2021-09
2. Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade Gliomas;Advances in Radiation Oncology;2020-03
3. Pharmacotherapeutics of capecitabine and trastuzumab in the treatment of metastatic breast cancer;British Journal of Nursing;2020-02-13
4. Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study;Journal of Cellular and Molecular Medicine;2019-09-30
5. Significance and expression of c-erBb-2, p53, and caspase-3 in breast cancer tissue in different age groups;EUR J GYNAECOL ONCOL;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3